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Transcription activator-like effector (TALE) nucleases (TALENs) have currently risen as a 
genome editing tool in numerous live forms .Transcription activator-like effector nucleases 
(TALENs), comprising of an DNA binding domain and a FokI cleavage domain TALENs can 
behaves  as adaptable  molecular DNA scissors creating  double-strand breaks (DSBs) at desired 
position of a genome, expanding the effectiveness of genomic modification. The TALE central 
repeat domains’s flexible nature empower to tailor DNA recognition specificity easily and target 
basically any desired DNA sequence. 
In this study we understood the structural basis of interaction between TALEN and DNA and the  
target binding site of TALEN was predicted. It was found that NH RVD binds Guanine more 
specifically than NN RVD and accordingly script of TALE NT TOOL 2.0(https://tale-
nt.cac.cornell.edu/node/add/talen) was modified. Adh2 and adh1c gene were tested in both the 
existing and modified script of TALE NT tool 2.0. Experiment shows that a 63 aa CTS in 
TALEN scaffold ,could lead to effective  gene modification in cells of human, when separated 
by 14-32 bp spacers and accordingly script of TALE NT was changed  with the spacer length 15-
30.The results of adh2 gene and adh1c gene were verified by online available tools of TALEN 
LIBRARY RESEARCH (http://www.talenlibrary.net/) and we got affirmative results. Thus, the 
modified script is expected to increase the efficiency of DNA targeting. 



































Genome editing, is a type of genetic engineering in which DNA is embedded, supplanted, or 
expelled from a genome utilizing engineered nucleases. Targeted genome modification (TGM), 
intervened by engineered nucleases, has beengenerally used to examine  gene function and 
expand  biotechnology applications in  various organisms. 
TALENs, a type of engineered nucleases consist of aTALE DNA binding domain and a FokI 
cleavage domain.The DNA binding domain, composed of various almost identical tandem repeat 
arrays, can target any given sequence as per a basic repeat variable di-residue (RVD)-nucleotide 
recognition code. 
As per this code, the HDrepeat specifies C, NG specifies T, NI specifies A, NN specifiesG or A, 
N* specifies C, IG specifies T, and NS specifiesA, C, G, or T. Albeit numerous common RVDs 
have been  foundfour of them, HD, NN, NI, and NG, represent  for75% of the aggregate. 
The discriminating venture in TGM is presentation of DNAdouble-strand breaks (DSBs) at 
desired genomic location. It wasbefore long found that designed nucleases could createDSBs and 
thus initiate DNA repair to seal the breaksalongside any changes, for example, transformations, 
insertions,substitutions. 
TALE-NT is a unreserved freely available tool for designing pairs of TAL effectors for TAL 
effector nucleases (TALENs) to target a specific gene sequence.Moreover, TALE-NT gives tools 
to design single TAL effectors to target to a DNA sequence, and to find binding sites in a DNA 
sequence for a given TAL effector. 
To find out the ideal TALEN building design with efficient cleavage activity and minimal 
peptide segment, scaffold optimization has been carried out.A methodical study was 
 9 
 
done by building 10 diverse TALEN scaffold with different NTSs and CTSs. The DNA cleavage 
action of every framework was examined against 10 substrates with diverse spacers in a yeast 
correspondent framework. Taking into account this 10_10network, two TALEN platforms with 
high DNA cleavage productivity in both yeast and human cells were distinguished. 
One bearing a 207 aa NTS and a 31 aa CTS inclines toward target destinations with 10–16 bp 
spacers while another bearing a 207 aa NTSalso, a 63 aa CTS has most noteworthy proficiency 
when differentiated by 14–32 bp spacers. Accordingly, the spacer length of the script was 
modified to 15-30 bp spacer length. 
It was additionally observed that NH RVD ties "G" more particularly than NN RVD. Keping this 
as a main priority the script of TALE NT was adjusted and two genes  in particular adh2 and 
adh1c were run through the current script of TALE NT  and through the changed version of 













The objective of this project is as followed  
 
 To understand the structural basis of interaction between Transcription Activator Like 
Effectors Nucleases and target DNA site.. 
 To analyze the  target prediction and scaffold optimization for genome editing in stem 






















TALE STRUCTURE AND RECOGNITION CODE  
Structure of TALE includes: 
 N terminal region which comprises  secretion and translocation signals  
 C terminal region consisting of nuclear localization signals (NLS)  
an acidic transcription-activation domain (AD)  
 A central DNA binding domain (DBD)  
DBD consist of amino acid repeat which is 33-35 aa long and containing only 20 amino acids in 







The DNA binding specificity of TALE is a characteristics property of repeat variable di-residue 
(RVD) in the location 12 and 13 of each repeat [2] [13]. 
 
Figure 1. Structure of TALE [1] 
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NN G or A 
N* C 
IG T 
NS A,C, G or T 
NH G 





Albeit numerous RVDs have been found, mainly HD, NN, NI, and NG, represent 75% of the 
aggregate [6] .NK show poor affinity toward G relative to NH [5]. The RVD sequence 
determines the specificity of DNA binding. The number of repeat corresponds to the total length 
of tarset site and RVD determines the nucleotide to be recognized in the target site. Besides all 
this, a thymine (T) succeeds the recognition sites and this is the basic principle of  TALENs for 
gene targeting. TAL repeat consists of 2 helices joined by a short RVD-containing loop, and all 
repeats form a right-handed superhelical structure that tracks along the sense strand of the DNA 
duplex, with the RVDs contacting the major groove [7]. The two hyper-variable residues have 






       Figure2. TALE-DNA interaction structure (side view) 
Table 1.RVDs and corresponding specific nucleotide  
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The amino acid in position 12 gives stability to the structure by interacting with the residue of 
repeats through hydrogen bond.The  amino acid in position 13 is responsible for the specificity 
of binding of TALE to specific nucleotide in the target site. [3] [4] 
 
 
          Figure 3.TALE –DNA interaction structure ( top view, along the axis of DNA groove) 





                                  Figure 5. Interaction of DNA with the repeat 14, 15, 16 
    
 
The residue at position 12 in each RVD arranges far from DNA and  interact with the carbonyl at 
position 8 in the first helix of protein backbone, and  hence gives stability to the loop.The residue 
at position 13 profound into DNA major groove and interacts with the specific nucleotide of 








SPECIFICITIES OF RVDs FOR “G” 
 
To check the specificities of RVD, Artificial TALEs (ArtTALs) was constructed where the initial 
six repeats were from natural TALE Hax3,containing several HD RVDs. There were total of 
-
glucuronidase (GUS) reporter constructs was tranfected into leaf cells of Nicotianabenthamiana. 
This man made setup was used to examine the RVD (known and new).The specificity for G was 
shown by NH RVD. When compared to NK, the G specific RVD NH was found to be much 
more efficient [14]. These RVD specificities will allow a highly specific targeting of guanine 
(NH)and a flexible targeting . 













 Figure 6: Specificity for G by different RVD 
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SCAFFOLD  OPTIMISATION 
 
TALEs which occurs naturally are transcription activators.  NTSs maintains protein secretion 
signal peptides.Their CTSs comprises of  nuclearlocalization signal peptides and a transcription 
activatordomain [10].From the experiments on yeast assay, between the two TALEN binding 
sites(NTS 288 aa and CTS 295 aa)  the spacer length was determined to be 16–31 bp. 
Alternatively, the TALENs (287 aa NTS and 231 aa CTS) was efficient with 13–30 bp spacers.  
To find out the ideal TALEN building design with most astoundingcleavage proficiency and 
minimal peptide segment, scaffold optimization has been carried out.A methodical study was 
done , in which 10 diverse TALEN scaffold with different NTSs and CTSs was built . The DNA 
cleavage action ofevery framework was examined against 10 substrates with diversespacers in a 
yeast correspondent framework. Taking into account this 10_10network, two TALEN platforms 
with high DNA cleavageproductivity in both yeast and human cells were 
distinguished.Onebearing a 207 aa NTS and a 31 aa CTS inclines toward target destinationswith 
10–16 bp spacers while another bearing a 207 aa NTSalso, a 63 aa CTS has most noteworthy 
proficiency when differentiated by 14–32 bp spacers (Table II) [14][9] 
                       
SR NO NTS CTS Spacer( bp) 
1 288 295 16-31 
2 288 285 16 
3 287 231 13-30 
4 287 63 15 
5 207 63 14-32 
6 207 31 10-16 
7 153 47 12-21 
8 153 17 12 
9 136 63 12-20 
10 136 28 12-13 
11 136 18 13-16 
 
















METHOD AND SOFTWARE REQUIREMENTS 
 
TALE NT TOOL 2.0 
 
The  tools are  located at /opt/boglab/talent  in the TALE NT software’s script file(by 
default).Following steps were followed to change the location of the tool.  
1.In talconfig.py,  the value of BASE_DIR  was changed to to the full path of the parent folder of 
boglab_tools 
2.In findTAL.py,  'talent' was changed to 'boglab_tools' in the line 'with open(BASE_DIR + 
"/talent/re_dict_dump", "rb")  as re_dict_file”. 
Boglab tools required  Python 2.6+  and Biopython,findRvdTAL  doest not work until 
boglab_tfcount , C libraries  are installed, And  findPairedRvdTALs.py  does not work until 
cython wrappers from boglab_talesf is installed. “findTAL.py” scripts in boglab_tools 
corresponds to the TALEN Targeter  in TALE NT Tool. 
Command to run script: 
 
python findTal.py OPTIONS 
Command to find the existing option 
 
Python findTAL.py --help 
Command for running findTAL.py : 
 
Python findTAL.py – filter’0’ –gspec—min 





 Here min represents minimum spacer length, max represents maximum spacer length, arraymin 
represents minimum RVD sequence length, arraymax represents maximum RVD sequence 
length, fasta represents path to the file containing input sequences in FASTA format, gspec uses 
NH instead of NN for G 
PYTHON: 
 
Install python by following this command: 
 
Python 3.4 setup.py build 
Python 3.4 setup.py test 
Sudo python 3.4 setup.py install 
 
 After installation of python, we installed biopthon. 
BIOPYTHON: 
To install the biopython, zip format of source code was downloaded  and source code  were 
unzipped. 
 
For installation, the following commands were 
typed in the directory  
Python setup.py build 
Python setup.py test 
Sudo python setup.py install 
 To test python and biopython installation, the following code were typed in biopytho source 





Following softwares were installed to use tfcount: 
1.NVIDIA GPU 2.0+  





To install tfcount, following command 





Python setup.py build-ext 
Python setup.py install 
 
 
Following commands were typed to run 
tfcount 
 






Following commands were typed in the 




























































Run the fasta sequence of ADH1C and ADH2 gene in the script file of TALE NT tool and in the 
modified script of TALE NT TOOL. 
 
Script of TALEN Targeter  was written on the basis of following criteria: 
 “T” should preceed before the TALEN recognition site/target site. 
 The target site selected should be unique in nature and nucleotide code. 
 For each TALEN, there should be at least 14 tandem repeats in the DNA binding site of 
TALE. 
 To stabilize the interaction between TALE –DNA there should be at least four strong 
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RVDs (HD, NG, NN). 
 Furthermore, there should be strong RVD at the termini of the TALE sequence. 
 Stretches should be avoided for 3 identical RVDs, as there can be deformation in the 
structure due to the presence of same consecutive RVD. 
 For targeting “G”, use NH instead of NN as NH is more specifie toward “G”. 
 Use the spacer length to be 15-30 bp for scaffold optimisation. 
 There should not be any T at position one or position two. 
 No “G” should be present at the end of half site of the target sequence. 















Different softwares required  like  Biopython, python 2.6+, NVIDIA GPU 2.0+, 
CUDA toolkit were downloaded and  installed successfully following the code in 
TALE NT site. 
 
Script were taken from TALE NT TOOL (https://tale-
nt.cac.cornell.edu/node/add/talen) and modified on the basis  of specificity of RVD for 
“G” and spacer length 
 
The two genes, ADH1c and ADH2 were run both  in the existing and modified script 
of TALE NT TOOL 2.0 
 
Testing and verification of script was  done by online available tool  of TALE NT 














RESULTS AND DISCUSSION  
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RESULT AND DISCUSSION: 
In the Script of TALE NT, the minimum RVD sequence length was 15 and the maximum RVD 
sequence length was 20. The spacer length was taken to be 15-20 bp. Besides all this, a thymine 
(T) succeeds the recognition sites, which is the basic principle of TALENs for gene targeting. 
In the modified script, the minimum RVD sequence length was 15 and maximum was 20. The 
spacer length was taken as 15-30 and NH is taken as the RVD which will recognize and interact 
with “G”.For the verification of data from the script, we have tested the genes in the online 
TALE NT TOOL, and it was found to be same as of the script. This verifies the procedure 
followed in running the script. 






1 T ATATGAGCAAACAAAAT 
 
ATGCACTCAAGCAGAG 
NI NG NI NG NN NI NN HD NI NINI HD NI NININI NG 
 
HD NG HD NG NN HD NG NG NN NI NN NG NN HD NI NG 
2 T CCTCTACCCTACATGAT 
 
ATTAATTCTGCTCTTCAG 
HD HD NG HD NG NI HD HDHD NG NI HD NI NG NN NI NG 
HD HD NG HD NG NI HD HDHD NG NI HD NI NG NN NI NG 
3 T CCTCTACCCTACATGAT 
 
ATTAATTCTGCTCTTCAGAG 
HD HD NG HD NG NI HD HDHD NG NI HD NI NG NN NI NG  
HD NG HD NG NN NI NI NN NI NN HD NI NN NI NI NG NG NI NI NG 
4 T CCTCTACCCTACATGAT 
 
AATTCTGCTCTTCAGAG 
HD HD NG HD NG NI HD HDHD NG NI HD NI NG NN NI NG  
HD NG HD NG NN NI NI NN NI NN HD NI NN NI NI NG NG 
5 T CCTCTACCCTACATGATCT 
 
ATTAATTCTGCTCTTCAG 
HD HD NG HD NG NI HD HDHD NG NI HD NI NG NN NI NG HD NG
  
HD NG NN NI NI NN NI NN HD NI NN NI NI NG NG NI NI NG 
 





SR NO TARGET SITE RVD SEQUENCE 
1 T CTGAATGACCCCTGT 
 
GAAGCAGGAACTTGAGAG 
HD NG NH NI NI NG NH NI HD HDHDHD NG NH NG  
HD NG HD NG HD NI NI NH NG NG HD HD NG NH HD NG NG HD 
2 T CTGAATGACCCCTGTG 
 
AAGCAGGAACTTGAGAGAGG 
HD NG NH NI NI NG NH NI HD HDHDHD NG NH NG NH 
HD HD NG HD NG HD NG HD NI NI NH NG NG HD HD NG NH HD NG 
NG 
3 T CTGAATGACCCCTGTGG 
 
AGCAGGAACTTGAGAGAGG 
HD NG NH NI NI NG NH NI HD HDHDHD NG NH NG NH NH 
HD HD NG HD NG HD NG HD NI NI NH NG NG HD HD NG NH HD NG 
4 T CTGAATGACCCCTGTGG 
 
CAGGAACTTGAGAGAGGAGG 
HD NG NH NI NI NG NH NI HD HDHDHD NG NH NG NH NH  
HD HD NG HD HD NG HD NG HD NG HD NI NI NH NG NG HD HD NG 
NH 
5 T CTGAATGACCCCTGTGGGT 
 
CAGGAACTTGAGAGAGGAGG 
HD NG NH NI NI NG NH NI HD HDHDHD NG NH NG NH NHNH NG 
HD HD NG HD HD NG HD NG HD NG HD NI NI NH NG NG HD HD NG 
NH 
 




TARGET SITE RVD SEQUENCE 




NG NG NI NI HD NG NH NHNH NG NGNG HD HD NG NI HD NI 
 







 NG NG NI NI HD NG NH NHNH NG NGNG HD HD NG NG 
 
HD HD NG NI HD NI HD NI NG HD HD NI NI NG NG NI NI NG NG NI 




NG NG NI NI HD NG NH NHNH NG NGNG HD HD NG NG NH 
 
HD HD NG NI HD NI HD NI NG HD HD NI NI NG NG NI NI NG NG 




NG NG NI NI HD NG NH NHNH NG NGNG HD HD NG NG NH NI NG 
 





NG NI NI HD NG NH NHNH NG NGNG HD HD NG NG NH NI NG NG 
NH 
 
HD HD NI HD NI NI NG HD HD NG NI HD NI HD NI NG HD HD NI NI 
 





SR NO. TARGET SITE RVD SEQUENCE 
1 T CTAGTTATGTAGCTCCT 
 
AGGAAATTTGGTGTGACCG  
HD NG NI NN NG NG NI NG NN NG NI NN HD NG HD HD NG 
HD NN NN NG HD NI HD NI HD HD NI NINI NG NGNG HD HD 
NG 
2 T GCAATTGCATTGTAGT 
 
ATAAAACTGCAGTTTGG  
NN HD NI NI NG NG NN HD NI NG NG NN NG NI NN NG  
HD HD NI NINI HD NG NN HD NI NN NG NGNGNG NI NG 
3 T GCAATTGCATTGTAGT 
 
AAAACTGCAGTTTGG  
NN HD NI NI NG NG NN HD NI NG NG NN NG NI NN NG 
HD HD NI NINI HD NG NN HD NI NN NG NGNGNG 
4 T AGTTATGTAGCTCCT 
 
AGGAAATTTGGTGTGACCG 
NI NN NG NG NI NG NN NG NI NN HD NG HD HD NG 
HD NN NN NG HD NI HD NI HD HD NI NINI NG NGNG HD HD 
NG 
5 T AGTTATGTAGCTCCTAT 
 
AGGAAATTTGGTGTGACCG 
NI NN NG NG NI NG NN NG NI NN HD NG HD HD NG NI NG
  
HD NN NN NG HD NI HD NI HD HD NI NINI NG NGNG HD HD 
NG 





The Transcription Activator Like Effector (TALE) structure was understood and the analysis of 
the interaction between TALE and target DNA site was done followed by modifying the python 
script of TALE NT TOOL on the basis of “G” specificity parameter and spacer length. Two 
genes namely ADH2 and ADH1C were tested in the script of TALE NT and results were verified 
using an online tool of TALE NT TOOL 2.0 (https://tale-nt.cac.cornell.edu/node/add/talen) and 
TALEN LIBRARY RESOURCE (http://www.talenlibrary.net/). Results from online tool found 
to be in coordination with the results from the python script.This verifies our TALEN sequence 
found from the script. And, thus the script with modification parameters will increase the  
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Adh2 gene (Existing script) 
table_ignores:TAL1 length,TAL2 length,Spacer length 
options_used:array_min = 15, array_max = 20, spacer_min = 15, spacer_max = 30, upstream_base = T, 
No T at position 1, No A at position 1, Sites must end in a T, Sites may not end in G/NN, Base 
composition rules enforced 
Sequence Name TAL1 start TAL2 start TAL1 length TAL2 length Spacer length
 Spacer range TAL1 RVDs TAL2 RVDs Plus strand sequence
 Unique_RE_sites_in_spacer 
gi|156074003|gb|EF520859.1| 769 832 17 19 28 786-813 HD NG NI NN 
NG NG NI NG NN NG NI NN HD NG HD HD NG HD NN NN NG HD NI HD NI HD HD NI NI NI NG NG NG 
HD HD NG T CTAGTTATGTAGCTCCT attcattgcctatttcttgtaaacagct AGGAAATTTGGTGTGACCG A
 BsrDI:GCAATG|CATTGC 
gi|156074003|gb|EF520859.1| 898 945 16 17 15 914-928 NN HD NI NI NG 
NG NN HD NI NG NG NN NG NI NN NG HD HD NI NI NI HD NG NN HD NI NN NG NG NG NG NI NG
 T GCAATTGCATTGTAGT ggtgaagatagaaat ATAAAACTGCAGTTTGG A MboII:GAAGA|TCTTC 
gi|156074003|gb|EF520859.1| 898 945 16 15 17 914-930 NN HD NI NI NG 
NG NN HD NI NG NG NN NG NI NN NG HD HD NI NI NI HD NG NN HD NI NN NG NG NG NG T 
GCAATTGCATTGTAGT ggtgaagatagaaatat AAAACTGCAGTTTGG A MboII:GAAGA|TCTTC 
gi|156074003|gb|EF520859.1| 771 832 15 19 28 786-813 NI NN NG NG NI 
NG NN NG NI NN HD NG HD HD NG HD NN NN NG HD NI HD NI HD HD NI NI NI NG NG NG HD HD 
NG T AGTTATGTAGCTCCT attcattgcctatttcttgtaaacagct AGGAAATTTGGTGTGACCG A
 BsrDI:GCAATG|CATTGC 
gi|156074003|gb|EF520859.1| 771 832 17 19 26 788-813 NI NN NG NG NI 
NG NN NG NI NN HD NG HD HD NG NI NG HD NN NN NG HD NI HD NI HD HD NI NI NI NG NG NG 
HD HD NG T AGTTATGTAGCTCCTAT tcattgcctatttcttgtaaacagct AGGAAATTTGGTGTGACCG A
 BsrDI:GCAATG|CATTGC 
gi|156074003|gb|EF520859.1| 771 832 17 16 29 788-816 NI NN NG NG NI 
NG NN NG NI NN HD NG HD HD NG NI NG HD NN NN NG HD NI HD NI HD HD NI NI NI NG NG NG
 T AGTTATGTAGCTCCTAT tcattgcctatttcttgtaaacagctagg AAATTTGGTGTGACCG A
 BsrDI:GCAATG|CATTGC 
gi|156074003|gb|EF520859.1| 771 832 17 15 30 788-817 NI NN NG NG NI 
NG NN NG NI NN HD NG HD HD NG NI NG HD NN NN NG HD NI HD NI HD HD NI NI NI NG NG




gi|156074003|gb|EF520859.1| 775 832 17 19 22 792-813 NI NG NN NG NI 
NN HD NG HD HD NG NI NG NG HD NI NG HD NN NN NG HD NI HD NI HD HD NI NI NI NG NG NG 
HD HD NG T ATGTAGCTCCTATTCAT tgcctatttcttgtaaacagct AGGAAATTTGGTGTGACCG A none 
gi|156074003|gb|EF520859.1| 775 832 17 16 25 792-816 NI NG NN NG NI 
NN HD NG HD HD NG NI NG NG HD NI NG HD NN NN NG HD NI HD NI HD HD NI NI NI NG NG NG
 T ATGTAGCTCCTATTCAT tgcctatttcttgtaaacagctagg AAATTTGGTGTGACCG A none 
gi|156074003|gb|EF520859.1| 775 832 17 15 26 792-817 NI NG NN NG NI 
NN HD NG HD HD NG NI NG NG HD NI NG HD NN NN NG HD NI HD NI HD HD NI NI NI NG NG
 T ATGTAGCTCCTATTCAT tgcctatttcttgtaaacagctagga AATTTGGTGTGACCG A none 
gi|156074003|gb|EF520859.1| 264 318 17 17 21 281-301 HD NN NG NG 
NN NN NI NI HD NG NG HD NI NI HD HD NG NN NN HD NI NI NN NI HD NI NI HD HD NI NI HD NI NG
 T CGTTGGAACTTCAACCT tcagtgaatacaccgttcttc ATGTTGGTTGTCTTGCC A MboII:GAAGA|TCTTC 
gi|156074003|gb|EF520859.1| 264 321 17 20 21 281-301 HD NN NG NG 
NN NN NI NI HD NG NG HD NI NI HD HD NG HD NG NG NN NN HD NI NI NN NI HD NI NI HD HD NI NI 
HD NI NG T CGTTGGAACTTCAACCT tcagtgaatacaccgttcttc ATGTTGGTTGTCTTGCCAAG A
 MboII:GAAGA|TCTTC 
gi|156074003|gb|EF520859.1| 264 318 18 17 20 282-301 HD NN NG NG 
NN NN NI NI HD NG NG HD NI NI HD HD NG NG NN NN HD NI NI NN NI HD NI NI HD HD NI NI HD NI NG
 T CGTTGGAACTTCAACCTT cagtgaatacaccgttcttc ATGTTGGTTGTCTTGCC A MboII:GAAGA|TCTTC 
gi|156074003|gb|EF520859.1| 264 321 18 20 20 282-301 HD NN NG NG 
NN NN NI NI HD NG NG HD NI NI HD HD NG NG HD NG NG NN NN HD NI NI NN NI HD NI NI HD HD NI NI 
HD NI NG T CGTTGGAACTTCAACCTT cagtgaatacaccgttcttc ATGTTGGTTGTCTTGCCAAG A
 MboII:GAAGA|TCTTC 
gi|156074003|gb|EF520859.1| 777 832 15 19 22 792-813 NN NG NI NN 
HD NG HD HD NG NI NG NG HD NI NG HD NN NN NG HD NI HD NI HD HD NI NI NI NG NG NG HD HD 
NG T GTAGCTCCTATTCAT tgcctatttcttgtaaacagct AGGAAATTTGGTGTGACCG A none 
gi|156074003|gb|EF520859.1| 777 832 15 16 25 792-816 NN NG NI NN 
HD NG HD HD NG NI NG NG HD NI NG HD NN NN NG HD NI HD NI HD HD NI NI NI NG NG NG T 
GTAGCTCCTATTCAT tgcctatttcttgtaaacagctagg AAATTTGGTGTGACCG A none 
gi|156074003|gb|EF520859.1| 777 832 15 15 26 792-817 NN NG NI NN 
HD NG HD HD NG NI NG NG HD NI NG HD NN NN NG HD NI HD NI HD HD NI NI NI NG NG T 
GTAGCTCCTATTCAT tgcctatttcttgtaaacagctagga AATTTGGTGTGACCG A none 
gi|156074003|gb|EF520859.1| 777 832 20 19 17 797-813 NN NG NI NN 
HD NG HD HD NG NI NG NG HD NI NG NG NN HD HD NG HD NN NN NG HD NI HD NI HD HD NI NI NI NG 





ADH2 GENE (modified script) 
table_ignores:TAL1 length,TAL2 length,Spacer length 
options_used:array_min = 15, array_max = 20, spacer_min = 15, spacer_max = 30, upstream_base = T 
Sequence Name Cut Site TAL1 start TAL2 start TAL1 length TAL2 length Spacer 
length Spacer range TAL1 RVDs TAL2 RVDs Plus strand sequence Unique RE sites in 
spacer % RVDs HD or NN/NH 
gi|156074003|gb|EF520859.1| 26 4 51 15 18 15 19-33 NG NG NI NI HD 
NG NH NH NH NG NG NG HD HD NG NI HD NI HD NI NG HD HD NI NI NG NG NI NI NG NG NI NI
 T TTAACTGGGTTTCCT tgattgattggtgtt TTAATTAATTGGATGTGT A none 30 
gi|156074003|gb|EF520859.1| 27 4 54 16 20 15 20-34 NG NG NI NI HD 
NG NH NH NH NG NG NG HD HD NG NG HD HD NG NI HD NI HD NI NG HD HD NI NI NG NG NI NI NG NG 
NI T TTAACTGGGTTTCCTT gattgattggtgttt TAATTAATTGGATGTGTAGG A none 33 
gi|156074003|gb|EF520859.1| 28 4 54 17 19 15 21-35 NG NG NI NI HD 
NG NH NH NH NG NG NG HD HD NG NG NH HD HD NG NI HD NI HD NI NG HD HD NI NI NG NG NI NI 
NG NG T TTAACTGGGTTTCCTTG attgattggtgtttt AATTAATTGGATGTGTAGG A none 36 
gi|156074003|gb|EF520859.1| 29 4 54 18 18 15 22-36 NG NG NI NI HD 
NG NH NH NH NG NG NG HD HD NG NG NH NI HD HD NG NI HD NI HD NI NG HD HD NI NI NG NG NI NI 
NG T TTAACTGGGTTTCCTTGA ttgattggtgtttta ATTAATTGGATGTGTAGG A none 36 
gi|156074003|gb|EF520859.1| 30 4 54 19 17 15 23-37 NG NG NI NI HD 
NG NH NH NH NG NG NG HD HD NG NG NH NI NG HD HD NG NI HD NI HD NI NG HD HD NI NI NG 
NG NI NI T TTAACTGGGTTTCCTTGAT tgattggtgttttaa TTAATTGGATGTGTAGG A none 36 
gi|156074003|gb|EF520859.1| 31 4 61 17 20 21 21-41 NG NG NI NI HD 
NG NH NH NH NG NG NG HD HD NG NG NH HD HD NI HD NI NI NG HD HD NG NI HD NI HD NI NG HD 
HD NI NI T TTAACTGGGTTTCCTTG attgattggtgttttaattaa TTGGATGTGTAGGATTGTGG A
 PacI:TTAATTAA 43 
gi|156074003|gb|EF520859.1| 32 4 61 19 20 19 23-41 NG NG NI NI HD 
NG NH NH NH NG NG NG HD HD NG NG NH NI NG HD HD NI HD NI NI NG HD HD NG NI HD NI HD 
NI NG HD HD NI NI T TTAACTGGGTTTCCTTGAT tgattggtgttttaattaa TTGGATGTGTAGGATTGTGG A
 PacI:TTAATTAA 41 
gi|156074003|gb|EF520859.1| 33 5 61 20 20 17 25-41 NG NI NI HD NG 
NH NH NH NG NG NG HD HD NG NG NH NI NG NG NH HD HD NI HD NI NI NG HD HD NG NI HD NI HD 
NI NG HD HD NI NI T TAACTGGGTTTCCTTGATTG attggtgttttaattaa TTGGATGTGTAGGATTGTGG A
 PacI:TTAATTAA 43 
gi|156074003|gb|EF520859.1| 34 6 61 20 20 16 26-41 NI NI HD NG NH 
NH NH NG NG NG HD HD NG NG NH NI NG NG NH NI HD HD NI HD NI NI NG HD HD NG NI HD NI HD 
NI NG HD HD NI NI T AACTGGGTTTCCTTGATTGA ttggtgttttaattaa TTGGATGTGTAGGATTGTGG A
 PacI:TTAATTAA 43 
 36 
 
gi|156074003|gb|EF520859.1| 35 6 63 20 20 18 26-43 NI NI HD NG NH 
NH NH NG NG NG HD HD NG NG NH NI NG NG NH NI HD NG HD HD NI HD NI NI NG HD HD NG NI HD 
NI HD NI NG HD HD T AACTGGGTTTCCTTGATTGA ttggtgttttaattaatt GGATGTGTAGGATTGTGGAG A
 AseI:ATTAAT PacI:TTAATTAA 45 
gi|156074003|gb|EF520859.1| 36 10 63 19 20 15 29-43 NH NH NH NG 
NG NG HD HD NG NG NH NI NG NG NH NI NG NG NH HD NG HD HD NI HD NI NI NG HD HD NG NI HD 
NI HD NI NG HD HD T GGGTTTCCTTGATTGATTG gtgttttaattaatt GGATGTGTAGGATTGTGGAG A
 AseI:ATTAAT PacI:TTAATTAA 46 
gi|156074003|gb|EF520859.1| 37 10 63 20 19 15 30-44 NH NH NH NG 
NG NG HD HD NG NG NH NI NG NG NH NI NG NG NH NH HD NG HD HD NI HD NI NI NG HD HD 
NG NI HD NI HD NI NG HD T GGGTTTCCTTGATTGATTGG tgttttaattaattg GATGTGTAGGATTGTGGAG 
A AseI:ATTAAT PacI:TTAATTAA 46 
gi|156074003|gb|EF520859.1| 38 10 63 20 18 16 30-45 NH NH NH NG 
NG NG HD HD NG NG NH NI NG NG NH NI NG NG NH NH HD NG HD HD NI HD NI NI NG HD HD 
NG NI HD NI HD NI NG T GGGTTTCCTTGATTGATTGG tgttttaattaattgg ATGTGTAGGATTGTGGAG A
 AseI:ATTAAT PacI:TTAATTAA 45 
gi|156074003|gb|EF520859.1| 39 5 73 20 20 29 25-53 NG NI NI HD NG 
NH NH NH NG NG NG HD HD NG NG NH NI NG NG NH HD NH HD HD NI NI HD NI HD NG HD NG HD HD 
NI HD NI NI NG HD T TAACTGGGTTTCCTTGATTG attggtgttttaattaattggatgtgtag 
GATTGTGGAGAGTGTTGGCG A AseI:ATTAAT FokI:GGATG|CATCC BtsCI:GGATG|CATCC PacI:TTAATTAA
 48 
gi|156074003|gb|EF520859.1| 40 6 73 20 20 28 26-53 NI NI HD NG NH 
NH NH NG NG NG HD HD NG NG NH NI NG NG NH NI HD NH HD HD NI NI HD NI HD NG HD NG HD HD 
NI HD NI NI NG HD T AACTGGGTTTCCTTGATTGA ttggtgttttaattaattggatgtgtag 
GATTGTGGAGAGTGTTGGCG A AseI:ATTAAT FokI:GGATG|CATCC BtsCI:GGATG|CATCC PacI:TTAATTAA
 48 
gi|156074003|gb|EF520859.1| 41 10 73 19 20 25 29-53 NH NH NH NG 
NG NG HD HD NG NG NH NI NG NG NH NI NG NG NH HD NH HD HD NI NI HD NI HD NG HD NG HD HD 
NI HD NI NI NG HD T GGGTTTCCTTGATTGATTG gtgttttaattaattggatgtgtag 
GATTGTGGAGAGTGTTGGCG A AseI:ATTAAT FokI:GGATG|CATCC BtsCI:GGATG|CATCC PacI:TTAATTAA
 49 
gi|156074003|gb|EF520859.1| 42 10 73 20 20 24 30-53 NH NH NH NG 
NG NG HD HD NG NG NH NI NG NG NH NI NG NG NH NH HD NH HD HD NI NI HD NI HD NG HD 
NG HD HD NI HD NI NI NG HD T GGGTTTCCTTGATTGATTGG tgttttaattaattggatgtgtag 





ADH1C GENE (Existing script) 
table_ignores:TAL1 length,TAL2 length,Spacer length 
options_used:array_min = 15, array_max = 20, spacer_min = 15, spacer_max = 30, upstream_base = T, No T at 
position 1, No A at position 1, Sites must end in a T, Sites may not end in G/NN, Base composition rules enforced 
Sequence Name TAL1 start TAL2 start TAL1 length TAL2 length Spacer length Spacer 
range TAL1 RVDs TAL2 RVDs Plus strand sequence Unique_RE_sites_in_spacer 
gi|589269186|ref|NM_000669.4| 256 314 17 16 26 273-298 NI NG NI NG NN NI NN HD 
NI NI NI HD NI NI NI NI NG HD NG HD NG NN HD NG NG NN NI NN NG NN HD NI NG T ATATGAGCAAACAAAAT 
aaatacctgtgcaacatacctgcttt ATGCACTCAAGCAGAG A BfuAI:ACCTGC|GCAGGT BspMI:ACCTGC|GCAGGT 
gi|589269186|ref|NM_000669.4| 1537 1595 17 18 24 1554-1577 HD HD NG HD NG 
NI HD HD HD NG NI HD NI NG NN NI NG HD NG NN NI NI NN NI NN HD NI NN NI NI NG NG NI NI NG T 
CCTCTACCCTACATGAT ctggagcaacagctaggaaatatc ATTAATTCTGCTCTTCAG A BfaI:CTAG BpmI:CTGGAG|CTCCAG 
gi|589269186|ref|NM_000669.4| 1537 1597 17 20 24 1554-1577 HD HD NG HD NG 
NI HD HD HD NG NI HD NI NG NN NI NG HD NG HD NG NN NI NI NN NI NN HD NI NN NI NI NG NG NI NI NG
 T CCTCTACCCTACATGAT ctggagcaacagctaggaaatatc ATTAATTCTGCTCTTCAGAG A BfaI:CTAG 
BpmI:CTGGAG|CTCCAG 
gi|589269186|ref|NM_000669.4| 1537 1597 17 17 27 1554-1580 HD HD NG HD NG 
NI HD HD HD NG NI HD NI NG NN NI NG HD NG HD NG NN NI NI NN NI NN HD NI NN NI NI NG NG T 
CCTCTACCCTACATGAT ctggagcaacagctaggaaatatcatt AATTCTGCTCTTCAGAG A BfaI:CTAG BpmI:CTGGAG|CTCCAG 
gi|589269186|ref|NM_000669.4| 1537 1597 17 16 28 1554-1581 HD HD NG HD NG 
NI HD HD HD NG NI HD NI NG NN NI NG HD NG HD NG NN NI NI NN NI NN HD NI NN NI NI NG T 
CCTCTACCCTACATGAT ctggagcaacagctaggaaatatcatta ATTCTGCTCTTCAGAG A BfaI:CTAG BpmI:CTGGAG|CTCCAG 
gi|589269186|ref|NM_000669.4| 1537 1595 19 18 22 1556-1577 HD HD NG HD NG 
NI HD HD HD NG NI HD NI NG NN NI NG HD NG HD NG NN NI NI NN NI NN HD NI NN NI NI NG NG NI NI NG
 T CCTCTACCCTACATGATCT ggagcaacagctaggaaatatc ATTAATTCTGCTCTTCAG A BfaI:CTAG 
gi|589269186|ref|NM_000669.4| 1537 1597 19 20 22 1556-1577 HD HD NG HD NG 
NI HD HD HD NG NI HD NI NG NN NI NG HD NG HD NG HD NG NN NI NI NN NI NN HD NI NN NI NI NG NG NI 
NI NG T CCTCTACCCTACATGATCT ggagcaacagctaggaaatatc ATTAATTCTGCTCTTCAGAG A BfaI:CTAG 
gi|589269186|ref|NM_000669.4| 1537 1597 19 17 25 1556-1580 HD HD NG HD NG 
NI HD HD HD NG NI HD NI NG NN NI NG HD NG HD NG HD NG NN NI NI NN NI NN HD NI NN NI NI NG NG
 T CCTCTACCCTACATGATCT ggagcaacagctaggaaatatcatt AATTCTGCTCTTCAGAG A BfaI:CTAG 
gi|589269186|ref|NM_000669.4| 1537 1597 19 16 26 1556-1581 HD HD NG HD NG 
NI HD HD HD NG NI HD NI NG NN NI NG HD NG HD NG HD NG NN NI NI NN NI NN HD NI NN NI NI NG T 
CCTCTACCCTACATGATCT ggagcaacagctaggaaatatcatta ATTCTGCTCTTCAGAG A BfaI:CTAG 
gi|589269186|ref|NM_000669.4| 258 314 15 16 26 273-298 NI NG NN NI NN HD NI NI 
NI HD NI NI NI NI NG HD NG HD NG NN HD NG NG NN NI NN NG NN HD NI NG T ATGAGCAAACAAAAT 
aaatacctgtgcaacatacctgcttt ATGCACTCAAGCAGAG A BfuAI:ACCTGC|GCAGGT BspMI:ACCTGC|GCAGGT 
gi|589269186|ref|NM_000669.4| 1131 1191 16 20 25 1147-1171 NN HD NG NI NI 
NI NN NN NI NI NI NG NN NI HD NG NN NG HD NI NI NN HD HD NN NI HD HD NN NI NG NN NI HD NG NG
 T GCTAAAGGAAATGACT gatggaggtgtggatttttcgtttg AAGTCATCGGTCGGCTTGAC A none 
 38 
 
gi|589269186|ref|NM_000669.4| 1540 1595 16 18 22 1556-1577 HD NG NI HD HD 
HD NG NI HD NI NG NN NI NG HD NG HD NG NN NI NI NN NI NN HD NI NN NI NI NG NG NI NI NG T 
CTACCCTACATGATCT ggagcaacagctaggaaatatc ATTAATTCTGCTCTTCAG A BfaI:CTAG 
gi|589269186|ref|NM_000669.4| 1540 1597 16 20 22 1556-1577 HD NG NI HD HD 
HD NG NI HD NI NG NN NI NG HD NG HD NG HD NG NN NI NI NN NI NN HD NI NN NI NI NG NG NI NI NG
 T CTACCCTACATGATCT ggagcaacagctaggaaatatc ATTAATTCTGCTCTTCAGAG A BfaI:CTAG 
gi|589269186|ref|NM_000669.4| 1540 1597 16 17 25 1556-1580 HD NG NI HD HD 
HD NG NI HD NI NG NN NI NG HD NG HD NG HD NG NN NI NI NN NI NN HD NI NN NI NI NG NG T 
CTACCCTACATGATCT ggagcaacagctaggaaatatcatt AATTCTGCTCTTCAGAG A BfaI:CTAG 
gi|589269186|ref|NM_000669.4| 1540 1597 16 16 26 1556-1581 HD NG NI HD HD 
HD NG NI HD NI NG NN NI NG HD NG HD NG HD NG NN NI NI NN NI NN HD NI NN NI NI NG T 
CTACCCTACATGATCT ggagcaacagctaggaaatatcatta ATTCTGCTCTTCAGAG A BfaI:CTAG 
gi|589269186|ref|NM_000669.4| 5 50 15 15 16 20-35 HD NG NN NI NI NG NN NI 
HD HD HD HD NG NN NG HD NG HD NI NI NN NG NG HD HD NG NN HD NG NG T CTGAATGACCCCTGT 
gggtttgagagaagag AAGCAGGAACTTGAG A none 
gi|589269186|ref|NM_000669.4| 5 52 15 17 16 20-35 HD NG NN NI NI NG NN NI 
HD HD HD HD NG NN NG HD NG HD NG HD NI NI NN NG NG HD HD NG NN HD NG NG T CTGAATGACCCCTGT 
gggtttgagagaagag AAGCAGGAACTTGAGAG A none 
gi|589269186|ref|NM_000669.4| 5 55 15 20 16 20-35 HD NG NN NI NI NG NN NI 
HD HD HD HD NG NN NG HD HD NG HD NG HD NG HD NI NI NN NG NG HD HD NG NN HD NG NG T 
CTGAATGACCCCTGT gggtttgagagaagag AAGCAGGAACTTGAGAGAGG A none 
gi|589269186|ref|NM_000669.4| 5 52 15 16 17 20-36 HD NG NN NI NI NG NN NI 
HD HD HD HD NG NN NG HD NG HD NG HD NI NI NN NG NG HD HD NG NN HD NG T CTGAATGACCCCTGT 
gggtttgagagaagaga AGCAGGAACTTGAGAG A none 
gi|589269186|ref|NM_000669.4| 5 55 15 19 17 20-36 HD NG NN NI NI NG NN NI 
HD HD HD HD NG NN NG HD HD NG HD NG HD NG HD NI NI NN NG NG HD HD NG NN HD NG T 
CTGAATGACCCCTGT gggtttgagagaagaga AGCAGGAACTTGAGAGAGG A none 
gi|589269186|ref|NM_000669.4| 5 55 15 16 20 20-39 HD NG NN NI NI NG NN NI 
HD HD HD HD NG NN NG HD HD NG HD NG HD NG HD NI NI NN NG NG HD HD NG T CTGAATGACCCCTGT 
gggtttgagagaagagaagc AGGAACTTGAGAGAGG A none 
gi|589269186|ref|NM_000669.4| 5 58 15 19 20 20-39 HD NG NN NI NI NG NN NI 
HD HD HD HD NG NN NG HD HD NG HD HD NG HD NG HD NG HD NI NI NN NG NG HD HD NG T 
CTGAATGACCCCTGT gggtttgagagaagagaagc AGGAACTTGAGAGAGGAGG A none 
gi|589269186|ref|NM_000669.4| 5 58 15 16 23 20-42 HD NG NN NI NI NG NN NI 
HD HD HD HD NG NN NG HD HD NG HD HD NG HD NG HD NG HD NI NI NN NG NG T CTGAATGACCCCTGT 
gggtttgagagaagagaagcagg AACTTGAGAGAGGAGG A none 
gi|589269186|ref|NM_000669.4| 5 58 15 15 24 20-43 HD NG NN NI NI NG NN NI 
HD HD HD HD NG NN NG HD HD NG HD HD NG HD NG HD NG HD NI NI NN NG T CTGAATGACCCCTGT 




ADH1C GENE (Modified Script) 
table_ignores:TAL1 length,TAL2 length,Spacer length 
options_used:array_min = 15, array_max = 20, spacer_min = 15, spacer_max = 30, upstream_base = T 
Sequence Name Cut Site TAL1 start TAL2 start TAL1 length TAL2 length Spacer 
length Spacer range TAL1 RVDs TAL2 RVDs Plus strand sequence Unique RE sites in 
spacer % RVDs HD or NN/NH 
gi|589269186|ref|NM_000669.4| 27 5 52 15 18 15 20-34 HD NG 
NH NI NI NG NH NI HD HD HD HD NG NH NG HD NG HD NG HD NI NI NH NG NG HD HD NG NH HD NG 
NG HD T CTGAATGACCCCTGT gggtttgagagaaga GAAGCAGGAACTTGAGAG A none 52 
gi|589269186|ref|NM_000669.4| 28 5 55 16 20 15 21-35 HD NG 
NH NI NI NG NH NI HD HD HD HD NG NH NG NH HD HD NG HD NG HD NG HD NI NI NH NG NG HD HD NG 
NH HD NG NG T CTGAATGACCCCTGTG ggtttgagagaagag AAGCAGGAACTTGAGAGAGG A none 53 
gi|589269186|ref|NM_000669.4| 29 5 55 17 19 15 22-36 HD NG 
NH NI NI NG NH NI HD HD HD HD NG NH NG NH NH HD HD NG HD NG HD NG HD NI NI NH NG NG 
HD HD NG NH HD NG T CTGAATGACCCCTGTGG gtttgagagaagaga AGCAGGAACTTGAGAGAGG A none
 56 
gi|589269186|ref|NM_000669.4| 30 5 58 17 20 17 22-38 HD NG 
NH NI NI NG NH NI HD HD HD HD NG NH NG NH NH HD HD NG HD HD NG HD NG HD NG HD NI NI 
NH NG NG HD HD NG NH T CTGAATGACCCCTGTGG gtttgagagaagagaag 
CAGGAACTTGAGAGAGGAGG A none 56 
gi|589269186|ref|NM_000669.4| 31 5 58 19 20 15 24-38 HD NG 
NH NI NI NG NH NI HD HD HD HD NG NH NG NH NH NH NG HD HD NG HD HD NG HD NG HD NG HD 
NI NI NH NG NG HD HD NG NH T CTGAATGACCCCTGTGGGT ttgagagaagagaag 
CAGGAACTTGAGAGAGGAGG A none 56 
gi|589269186|ref|NM_000669.4| 32 5 59 20 20 15 25-39 HD NG 
NH NI NI NG NH NI HD HD HD HD NG NH NG NH NH NH NG NG NG HD HD NG HD HD NG HD NG HD NG 
HD NI NI NH NG NG HD HD NG T CTGAATGACCCCTGTGGGTT tgagagaagagaagc 
AGGAACTTGAGAGAGGAGGA A none 53 
gi|589269186|ref|NM_000669.4| 33 5 61 20 20 17 25-41 HD NG 
NH NI NI NG NH NI HD HD HD HD NG NH NG NH NH NH NG NG HD NG NG HD HD NG HD HD NG HD NG 
HD NG HD NI NI NH NG NG HD T CTGAATGACCCCTGTGGGTT tgagagaagagaagcag 
GAACTTGAGAGAGGAGGAAG A none 53 
gi|589269186|ref|NM_000669.4| 34 7 61 20 20 15 27-41 NH NI 
NI NG NH NI HD HD HD HD NG NH NG NH NH NH NG NG NG NH HD NG NG HD HD NG HD HD NG HD NG 
HD NG HD NI NI NH NG NG HD T GAATGACCCCTGTGGGTTTG agagaagagaagcag 
GAACTTGAGAGAGGAGGAAG A none 53 
 40 
 
gi|589269186|ref|NM_000669.4| 35 7 63 20 20 17 27-43 NH NI 
NI NG NH NI HD HD HD HD NG NH NG NH NH NH NG NG NG NH HD NG HD NG NG HD HD NG HD HD NG 
HD NG HD NG HD NI NI NH NG T GAATGACCCCTGTGGGTTTG agagaagagaagcagga 
ACTTGAGAGAGGAGGAAGAG A none 53 
gi|589269186|ref|NM_000669.4| 36 7 65 20 20 19 27-45 NH NI 
NI NG NH NI HD HD HD HD NG NH NG NH NH NH NG NG NG NH HD NG HD NG HD NG NG HD HD NG HD 
HD NG HD NG HD NG HD NI NI T GAATGACCCCTGTGGGTTTG agagaagagaagcaggaac 
TTGAGAGAGGAGGAAGAGAG A none 53 
gi|589269186|ref|NM_000669.4| 37 7 66 20 20 20 27-46 NH NI 
NI NG NH NI HD HD HD HD NG NH NG NH NH NH NG NG NG NH NG HD NG HD NG HD NG NG HD HD NG 
HD HD NG HD NG HD NG HD NI T GAATGACCCCTGTGGGTTTG agagaagagaagcaggaact 
TGAGAGAGGAGGAAGAGAGA A none 53 
gi|589269186|ref|NM_000669.4| 38 11 65 20 20 15 31-45 NH NI 
HD HD HD HD NG NH NG NH NH NH NG NG NG NH NI NH NI NH HD NG HD NG HD NG NG HD HD NG HD 
HD NG HD NG HD NG HD NI NI T GACCCCTGTGGGTTTGAGAG aagagaagcaggaac 
TTGAGAGAGGAGGAAGAGAG A none 55 
gi|589269186|ref|NM_000669.4| 39 11 66 20 20 16 31-46 NH NI 
HD HD HD HD NG NH NG NH NH NH NG NG NG NH NI NH NI NH NG HD NG HD NG HD NG NG HD HD NG 
HD HD NG HD NG HD NG HD NI T GACCCCTGTGGGTTTGAGAG aagagaagcaggaact 
TGAGAGAGGAGGAAGAGAGA A none 55 
gi|589269186|ref|NM_000669.4| 40 5 74 20 20 30 25-54 HD NG 
NH NI NI NG NH NI HD HD HD HD NG NH NG NH NH NH NG NG NI NI NG NG NI HD NG NG NG HD NG 
HD NG HD NG NG HD HD NG HD T CTGAATGACCCCTGTGGGTT tgagagaagagaagcaggaacttgagagag 
GAGGAAGAGAGAAAGTAATT A BpuEI:CTTGAG|CTCAAG SmlI:CTYRAG 45 
gi|589269186|ref|NM_000669.4| 41 11 70 20 20 20 31-50 NH NI 
HD HD HD HD NG NH NG NH NH NH NG NG NG NH NI NH NI NH NI HD NG NG NG HD NG HD NG HD NG 
NG HD HD NG HD HD NG HD NG T GACCCCTGTGGGTTTGAGAG aagagaagcaggaacttgag 
AGAGGAGGAAGAGAGAAAGT A BpuEI:CTTGAG|CTCAAG SmlI:CTYRAG 53 
gi|589269186|ref|NM_000669.4| 42 7 76 20 20 30 27-56 NH NI 
NI NG NH NI HD HD HD HD NG NH NG NH NH NH NG NG NG NH NG NG NI NI NG NG NI HD NG NG NG 
HD NG HD NG HD NG NG HD HD T GAATGACCCCTGTGGGTTTG agagaagagaagcaggaacttgagagagga 
GGAAGAGAGAAAGTAATTAA A BpuEI:CTTGAG|CTCAAG MnlI:CCTC|GAGG SmlI:CTYRAG 43 
gi|589269186|ref|NM_000669.4| 43 11 74 20 20 24 31-54 NH NI 
HD HD HD HD NG NH NG NH NH NH NG NG NG NH NI NH NI NH NI NI NG NG NI HD NG NG NG HD NG 
HD NG HD NG NG HD HD NG HD T GACCCCTGTGGGTTTGAGAG aagagaagcaggaacttgagagag 
GAGGAAGAGAGAAAGTAATT A BpuEI:CTTGAG|CTCAAG SmlI:CTYRAG 48 
 
 
